Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tanja Elger
Observed names:
Elger, Tanja,
T Elger,
T. Elger
Institution:
University Hospital Regensburg
Observed institution:
University Hospital Regensburg
ORCID:
0009-0005-2087-1043
Observed ORCID:
0009-0005-2087-1043
OpenAlex ID:
A5027260107
Altered fecal bile acid composition in active ulcerative colitis
2023
·
Stefanie Sommersberger
, Stefan Gunawan
, et al.
·
Lipids in Health and Disease
·
49
PDF
Unique Metabolomic and Lipidomic Profile in Serum From Patients With Crohn’s Disease and Ulcerative Colitis Compared With Healthy Control Individuals
2023
·
Hauke Christian Tews
, Franziska Schmelter
, et al.
·
Inflammatory Bowel Diseases
·
27
PDF
Fecal and Urinary Adipokines as Disease Biomarkers
2023
·
Hauke C. Tews
, Tanja Elger
, et al.
·
Biomedicines
·
17
PDF
Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity
2023
·
Hauke Christian Tews
, Tanja Elger
, et al.
·
Lipids in Health and Disease
·
14
PDF
Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease Severity
2025
·
Muriel Huss
, Tanja Elger
, et al.
·
International Journal of Molecular Sciences
·
13
PDF
Elevated long-to-very-long-chain ceramide ratio correlates with disease severity in inflammatory bowel disease and primary sclerosing cholangitis
2025
·
Tanja Elger
, Muriel Huss
, et al.
·
Scientific Reports
·
12
PDF
Unique sterol metabolite shifts in inflammatory bowel disease and primary sclerosing cholangitis
2024
·
Silke Matysik
, Tanja Elger
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
12
Urinary chemerin as a potential biomarker for inflammatory bowel disease
2022
·
Stefan Gunawan
, Tanja Elger
, et al.
·
Frontiers in Medicine
·
9
PDF
Fecal Nervonic Acid as a Biomarker for Diagnosing and Monitoring Inflammatory Bowel Disease
2024
·
Claudia Kunst
, Tanja Elger
, et al.
·
Biomedicines
·
8
PDF
Interprofessional approach to personalized medication management and therapy optimization in IBD care
2025
·
Daniel Fleischmann
, Benedicta Binder
, et al.
·
Frontiers in Medicine
·
7
PDF
Minimally-invasive tracheostomy (MIT): A care bundle for safety improvement in high-risk critically ill patients
2024
·
Dennis Christoph Harrer
, Patricia Mester
, et al.
·
Journal of Clinical Anesthesia
·
7
Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis
2024
·
Ganimete Bajraktari
, Tanja Elger
, et al.
·
International Journal of Molecular Sciences
·
7
Biomodulatory therapy approach with lenalidomide in combination with pioglitazone, dexamethasone, and metronomic low-dose chemotherapy with treosulfan in patients with relapsed/refractory multiple myeloma > second-line.
2019
·
Daniel Heudobler
, Tanja Elger
, et al.
·
Journal of Clinical Oncology
·
7
Fistulising skin metastases in Crohn’s disease: a case report and review of the literature
2024
·
Tanja Elger
, Johanna Loibl
, et al.
·
Journal of Medical Case Reports
·
6
Decline in Serum Lysophosphatidylcholine Species in Patients with Severe Inflammatory Bowel Disease
2025
·
Hauke Christian Tews
, Tanja Elger
, et al.
·
Journal of Clinical Medicine
·
4
PDF
Urinary Hydroxyproline as an Inflammation-Independent Biomarker of Inflammatory Bowel Disease
2024
·
Muriel Huss
, Tanja Elger
, et al.
·
Gastroenterology Insights
·
4
Cholesteryl Ester Species but Not Serum Proprotein Convertase Subtilisin/Kexin Type 9 Levels Decline in Male Patients with Active Inflammatory Bowel Disease
2025
·
Angelika Hettenbach
, Tanja Elger
, et al.
·
Pathophysiology
·
3
Distinct metabolomic and lipidomic profiles in serum samples of patients with primary sclerosing cholangitis
2024
·
Tanja Fererberger
, Christa Buechler
, et al.
·
Frontiers in Medicine
·
3
PDF
Urinary soluble CD163 is a putative non-invasive biomarker for primary sclerosing cholangitis
2024
·
Tanja Elger
, Tanja Fererberger
, et al.
·
Experimental and Molecular Pathology
·
3
Elevated Serum Adiponectin Levels in Primary Sclerosing Cholangitis (PSC) Compared to Inflammatory Bowel Disease (IBD): A Potential Biomarker for PSC-IBD Screening
2026
·
Tanja Elger
, Muriel Huss
, et al.
·
Livers
·
2
PDF
P369 Altered fecal bile acid composition in active Ulcerative Colitis
2024
·
S Sommersberger
, S Gunawan
, et al.
·
Journal of Crohn s and Colitis
·
2
PDF
Elevated Serum Soluble CD137 in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis Highlights a Shared Immunoregulatory Signature
2026
·
Tanja Elger
, Muriel Huss
, et al.
·
Biomedicines
·
1
PDF
Reciprocal Serum Phosphatidylcholine Signatures Are Related to Intestinal Inflammation in Inflammatory Bowel Disease and Liver Fibrosis in Primary Sclerosing Cholangitis—An Exploratory Study
2026
·
Tanja Elger
, Muriel Huss
, et al.
·
Biomedicines
·
1
PDF
Serum phosphatidylinositol depletion associates with fecal calprotectin and disease severity in female and male IBD patients
2026
·
Hauke Christian Tews
, Muriel Huss
, et al.
·
Lipids in Health and Disease
·
1
Adiponectin als nicht invasiver Biomarker für primär sklerosierende Cholangitis
2024
·
T. Elger
, J. Loibl
, et al.
·
Zeitschrift für Gastroenterologie
·
1
Show more works
View as search
Works count:
49
Citation count:
220
H-index:
8
I10-index:
7
Year
Topic
Type